Product No. | Product Name | Quantity | Quantity |
| Effective: 20-Mar-06 | | |
PBL-11001-1 | Human IFN-alpha Sampler (12 species) | 2 x 104 ea | 2.0E +4 ea |
PBL-11100-1 | Human IFN-alphaA [alpha2a] | 5 x 106 | 5.0E +6 |
PBL-11101-1 | Human IFN-alphaA [alpha2a], carrier-free | 5 µg | 5 µg |
PBL-11101-2 | Human IFN-alphaA [alpha2a], carrier-free | 20 µg | 20 µg |
PBL-11105-1 | Human IFN-alpha2 [a2b] | 1 x 105 | 1.0E +5 |
PBL-11115-1 | Human IFN-alphaB2 [a8] | 1 x 105 | 1.0E +5 |
PBL-11120-1 | Human IFN-alphaC [a10] | 1 x 105 | 1.0E +5 |
PBL-11125-1 | Human IFN-alphaD [a1 (Val 114)] | 1 x 105 | 1.0E +5 |
PBL-11130-1 | Human IFN-alphaF [a21] | 1 x 105 | 1.0E +5 |
PBL-11135-1 | Human IFN-alphaG [a5] | 1 x 105 | 1.0E +5 |
PBL-11145-1 | Human IFN-alphaH2 [a14] | 1 x 105 | 1.0E +5 |
PBL-11150-1 | Human IFN-alphaI [a17] | 1 x 105 | 1.0E +5 |
PBL-11160-1 | Human IFN-alphaJ1 [a7] | 1 x 105 | 1.0E +5 |
PBL-11165-1 | Human IFN-alphaK [a6] | 1 x 105 | 1.0E +5 |
PBL-11175-1 | Human IFN-alpha1 [aD (Ala 114)] | 1 x 105 | 1.0E +5 |
PBL-11177-1 | Human IFN-alpha4a [aM1] | 1 x 105 | 1.0E +5 |
PBL-11180-1 | Human IFN-alpha4b [a4] | 1 x 105 | 1.0E +5 |
PBL-11190-1 | Human IFN-alphaWA [a16] | 1 x 105 | 1.0E +5 |
PBL-11200-1 | Universal Type I IFN [Human IFN-alphaA/D (BglII)] | 1 x 105 | 1.0E +5 |
PBL-11200-2 | Universal Type I IFN [Human IFN-alphaA/D (BglII)] | 1 x 106 | 1.0E +6 |
PBL-11350-1 | Human Leukocyte Interferon | 1 x 106 | 1.0E +6 |
PBL-11395-1 | Human IFN-omega | 25 µg | 25 µg |
PBL-11410-1 | Human IFN-beta1a | 1 x 105 | 1.0E +5 |
PBL-11410-2 | Human IFN-beta1a | 1 x 106 | 1.0E +6 |
PBL-11420-1 | Human IFN-beta1b | 1 x 105 | 1.0E +5 |
PBL-11450-1 | Human IFN-kappa | 50 µg | 50 µg |
PBL-11500-1 | Human IFN-gamma | 50 µg | 50 µg |
PBL-11500-2 | Human IFN-gamma | 100 µg | 100 µg |
PBL-11580-1 | Human IFN-gamma Soluble Receptor Chain 1 [CD119] | 10 µg | 10 µg |
PBL-11810-1 | Human Interleukin-2 | 10 µg | 10 µg |
PBL-11815-1 | Human Interleukin-3 (Multi-CSF) | 10 µg | 10 µg |
PBL-11960-1 | Granulocyte-Macrophage Colony-Stimulating Factor [GM-CSF] | 10 µg | 10 µg |
PBL-11965-1 | Erythropoietin [EPO] | 500 units | 500 U |
PBL-11970-1 | Human Growth Hormone | 100 µg | 100 µg |
PBL-11972-1 | Human Growth Hormone Releasing Factor (1-44), amide | 1 mg | 1 mg |
PBL-11974-1 | Human Growth Hormone Releasing Factor (1-29), amide | 1 mg | 1 mg |
PBL-11976-1 | Thymosin alpha1 | 500 µg | 500 µg |
PBL-12100-1 | Mouse IFN-alphaA | 1 x 105 | 1.0E +5 |
PBL-12295-1 | Mouse Limitin | 10 µg | 10 µg |
PBL-12400-1 | Mouse IFN-beta | 1 x 105 | 1.0E +5 |
PBL-12500-1 | Mouse IFN-gamma | 20 µg | 20 µg |
PBL-12500-2 | Mouse IFN-gamma | 100 µg | 100 µg |
PBL-12501-1 | Mouse IFN-gamma, carrier free | 20 µg | 20 µg |
PBL-12580-1 | Mouse IFN-gamma Soluble Receptor Chain1 [CD119] | 10 µg | 10 µg |
PBL-13100-1 | Rat IFN-alpha | 1 x 105 | 1.0E +5 |
PBL-13400-1 | Rat IFN-beta | 1 x 105 | 1.0E +5 |
PBL-13500-1 | Rat IFN-gamma | 10 µg | 10 µg |
PBL-13500-2 | Rat IFN-gamma | 100 µg | 100 µg |
PBL-13501-1 | Rat IFN-gamma, carrier-free | 10 µg | 10 µg |
PBL-13501-2 | Rat IFN-gamma, carrier-free | 100 µg | 100 µg |
PBL-14100-1 | Rhesus Monkey IFN-alpha | 1 x 105 | 1.0E +5 |
PBL-15100-1 | Feline IFN-alpha | 1 x 105 | 1.0E +5 |
PBL-17100-1 | Pig IFN-alpha | 1 x 105 | 1.0E +5 |
PBL-18610-1 | Ovine IFN-tau | 1 x 105 | 1.0E +5 |
PBL-19610-1 | Bovine IFN-tau | 1 x 105 | 1.0E +5 |
PBL-21100-1 | Mouse MAb to Human IFN-alpha, neutralizing | 50 µg | 50 µg |
PBL-21100-2 | Mouse MAb to Human IFN-alpha, neutralizing | 500 µg | 500 µg |
PBL-21101-1 | Mouse MAb to Human IFN-alpha, NON-neutralizing | 50 µg | 50 µg |
PBL-21105-1 | Mouse MAb to Human IFN-alpha, neutralizing | 50 µg | 50 µg |
PBL-21110-1 | Mouse MAb to Human IFN-alpha, neutralizing | 50 µg | 50 µg |
PBL-21112-1 | Mouse MAb to Human IFN-alpha, neutralizing | 50 µg | 50 µg |
PBL-21112-3 | Mouse MAB to Human IFN-alpha-FITC, neutralizing | 100 Tests | 100 Tests |
PBL-21116-1 | Mouse MAb to Human IFN-alpha, neutralizing | 50 µg | 50 µg |
PBL-21118-1 | Mouse MAb to Human IFN-alpha, neutralizing | 50 µg | 50 µg |
PBL-21125-1 | Mouse MAb to Human IFN-alpha, neutralizing | 50 µg | 50 µg |